Global Tumor Necrosis Factor Inhibitor Drug Supply, Demand and Key Producers, 2023-2029

Page: 106

Published Date: 01 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Tumor Necrosis Factor Inhibitor Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor.

This report studies the global Tumor Necrosis Factor Inhibitor Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Tumor Necrosis Factor Inhibitor Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Necrosis Factor Inhibitor Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Tumor Necrosis Factor Inhibitor Drug total production and demand, 2018-2029, (K Units)
Global Tumor Necrosis Factor Inhibitor Drug total production value, 2018-2029, (USD Million)
Global Tumor Necrosis Factor Inhibitor Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Necrosis Factor Inhibitor Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Tumor Necrosis Factor Inhibitor Drug domestic production, consumption, key domestic manufacturers and share
Global Tumor Necrosis Factor Inhibitor Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Tumor Necrosis Factor Inhibitor Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Tumor Necrosis Factor Inhibitor Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Tumor Necrosis Factor Inhibitor Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie Inc., Amgen Inc., Johnson & Johnson, UCB, Novartis AG, Pfizer, Inc., Merck & Co., Inc., CASI Pharmaceuticals and EPIRUS Biopharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor Necrosis Factor Inhibitor Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Tumor Necrosis Factor Inhibitor Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Tumor Necrosis Factor Inhibitor Drug Market, Segmentation by Type
Humira
Enbrel
Remicade
Simponi
Cimzia
Biosimilars

Global Tumor Necrosis Factor Inhibitor Drug Market, Segmentation by Application
Rheumatoid Arthritis
Psoriatic Arthritis
Juvenile Idiopathic Arthritis
Crohn’s Disease
Ulcerative Colitis
Others

Companies Profiled:
AbbVie Inc.
Amgen Inc.
Johnson & Johnson
UCB
Novartis AG
Pfizer, Inc.
Merck & Co., Inc.
CASI Pharmaceuticals
EPIRUS Biopharmaceuticals
LEO Pharma
PROBIOMED
Shanghai Pharmaceuticals Holding Co., Ltd.

Key Questions Answered
1. How big is the global Tumor Necrosis Factor Inhibitor Drug market?
2. What is the demand of the global Tumor Necrosis Factor Inhibitor Drug market?
3. What is the year over year growth of the global Tumor Necrosis Factor Inhibitor Drug market?
4. What is the production and production value of the global Tumor Necrosis Factor Inhibitor Drug market?
5. Who are the key producers in the global Tumor Necrosis Factor Inhibitor Drug market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Tumor Necrosis Factor Inhibitor Drug Introduction
    1.2 World Tumor Necrosis Factor Inhibitor Drug Supply & Forecast
        1.2.1 World Tumor Necrosis Factor Inhibitor Drug Production Value (2018 & 2022 & 2029)
        1.2.2 World Tumor Necrosis Factor Inhibitor Drug Production (2018-2029)
        1.2.3 World Tumor Necrosis Factor Inhibitor Drug Pricing Trends (2018-2029)
    1.3 World Tumor Necrosis Factor Inhibitor Drug Production by Region (Based on Production Site)
        1.3.1 World Tumor Necrosis Factor Inhibitor Drug Production Value by Region (2018-2029)
        1.3.2 World Tumor Necrosis Factor Inhibitor Drug Production by Region (2018-2029)
        1.3.3 World Tumor Necrosis Factor Inhibitor Drug Average Price by Region (2018-2029)
        1.3.4 North America Tumor Necrosis Factor Inhibitor Drug Production (2018-2029)
        1.3.5 Europe Tumor Necrosis Factor Inhibitor Drug Production (2018-2029)
        1.3.6 China Tumor Necrosis Factor Inhibitor Drug Production (2018-2029)
        1.3.7 Japan Tumor Necrosis Factor Inhibitor Drug Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Tumor Necrosis Factor Inhibitor Drug Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Tumor Necrosis Factor Inhibitor Drug Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Tumor Necrosis Factor Inhibitor Drug Demand (2018-2029)
    2.2 World Tumor Necrosis Factor Inhibitor Drug Consumption by Region
        2.2.1 World Tumor Necrosis Factor Inhibitor Drug Consumption by Region (2018-2023)
        2.2.2 World Tumor Necrosis Factor Inhibitor Drug Consumption Forecast by Region (2024-2029)
    2.3 United States Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.4 China Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.5 Europe Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.6 Japan Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.7 South Korea Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.8 ASEAN Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)
    2.9 India Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029)

3 World Tumor Necrosis Factor Inhibitor Drug Manufacturers Competitive Analysis
    3.1 World Tumor Necrosis Factor Inhibitor Drug Production Value by Manufacturer (2018-2023)
    3.2 World Tumor Necrosis Factor Inhibitor Drug Production by Manufacturer (2018-2023)
    3.3 World Tumor Necrosis Factor Inhibitor Drug Average Price by Manufacturer (2018-2023)
    3.4 Tumor Necrosis Factor Inhibitor Drug Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Tumor Necrosis Factor Inhibitor Drug Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Tumor Necrosis Factor Inhibitor Drug in 2022
        3.5.3 Global Concentration Ratios (CR8) for Tumor Necrosis Factor Inhibitor Drug in 2022
    3.6 Tumor Necrosis Factor Inhibitor Drug Market: Overall Company Footprint Analysis
        3.6.1 Tumor Necrosis Factor Inhibitor Drug Market: Region Footprint
        3.6.2 Tumor Necrosis Factor Inhibitor Drug Market: Company Product Type Footprint
        3.6.3 Tumor Necrosis Factor Inhibitor Drug Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Value Comparison
        4.1.1 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Comparison
        4.2.1 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Tumor Necrosis Factor Inhibitor Drug Consumption Comparison
        4.3.1 United States VS China: Tumor Necrosis Factor Inhibitor Drug Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Tumor Necrosis Factor Inhibitor Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Tumor Necrosis Factor Inhibitor Drug Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023)
    4.5 China Based Tumor Necrosis Factor Inhibitor Drug Manufacturers and Market Share
        4.5.1 China Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value (2018-2023)
        4.5.3 China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023)
    4.6 Rest of World Based Tumor Necrosis Factor Inhibitor Drug Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023)

5 Market Analysis by Type
    5.1 World Tumor Necrosis Factor Inhibitor Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Humira
        5.2.2 Enbrel
        5.2.3 Remicade
        5.2.4 Simponi
        5.2.5 Cimzia
        5.2.6 Biosimilars
    5.3 Market Segment by Type
        5.3.1 World Tumor Necrosis Factor Inhibitor Drug Production by Type (2018-2029)
        5.3.2 World Tumor Necrosis Factor Inhibitor Drug Production Value by Type (2018-2029)
        5.3.3 World Tumor Necrosis Factor Inhibitor Drug Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Tumor Necrosis Factor Inhibitor Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Rheumatoid Arthritis
        6.2.2 Psoriatic Arthritis
        6.2.3 Juvenile Idiopathic Arthritis
        6.2.4 Crohn’s Disease
        6.2.5 Ulcerative Colitis
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Tumor Necrosis Factor Inhibitor Drug Production by Application (2018-2029)
        6.3.2 World Tumor Necrosis Factor Inhibitor Drug Production Value by Application (2018-2029)
        6.3.3 World Tumor Necrosis Factor Inhibitor Drug Average Price by Application (2018-2029)

7 Company Profiles
    7.1 AbbVie Inc.
        7.1.1 AbbVie Inc. Details
        7.1.2 AbbVie Inc. Major Business
        7.1.3 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.1.4 AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 AbbVie Inc. Recent Developments/Updates
        7.1.6 AbbVie Inc. Competitive Strengths & Weaknesses
    7.2 Amgen Inc.
        7.2.1 Amgen Inc. Details
        7.2.2 Amgen Inc. Major Business
        7.2.3 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.2.4 Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Amgen Inc. Recent Developments/Updates
        7.2.6 Amgen Inc. Competitive Strengths & Weaknesses
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Details
        7.3.2 Johnson & Johnson Major Business
        7.3.3 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.3.4 Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Johnson & Johnson Recent Developments/Updates
        7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.4 UCB
        7.4.1 UCB Details
        7.4.2 UCB Major Business
        7.4.3 UCB Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.4.4 UCB Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 UCB Recent Developments/Updates
        7.4.6 UCB Competitive Strengths & Weaknesses
    7.5 Novartis AG
        7.5.1 Novartis AG Details
        7.5.2 Novartis AG Major Business
        7.5.3 Novartis AG Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.5.4 Novartis AG Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Novartis AG Recent Developments/Updates
        7.5.6 Novartis AG Competitive Strengths & Weaknesses
    7.6 Pfizer, Inc.
        7.6.1 Pfizer, Inc. Details
        7.6.2 Pfizer, Inc. Major Business
        7.6.3 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.6.4 Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Pfizer, Inc. Recent Developments/Updates
        7.6.6 Pfizer, Inc. Competitive Strengths & Weaknesses
    7.7 Merck & Co., Inc.
        7.7.1 Merck & Co., Inc. Details
        7.7.2 Merck & Co., Inc. Major Business
        7.7.3 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.7.4 Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck & Co., Inc. Recent Developments/Updates
        7.7.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
    7.8 CASI Pharmaceuticals
        7.8.1 CASI Pharmaceuticals Details
        7.8.2 CASI Pharmaceuticals Major Business
        7.8.3 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.8.4 CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CASI Pharmaceuticals Recent Developments/Updates
        7.8.6 CASI Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 EPIRUS Biopharmaceuticals
        7.9.1 EPIRUS Biopharmaceuticals Details
        7.9.2 EPIRUS Biopharmaceuticals Major Business
        7.9.3 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.9.4 EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 EPIRUS Biopharmaceuticals Recent Developments/Updates
        7.9.6 EPIRUS Biopharmaceuticals Competitive Strengths & Weaknesses
    7.10 LEO Pharma
        7.10.1 LEO Pharma Details
        7.10.2 LEO Pharma Major Business
        7.10.3 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.10.4 LEO Pharma Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 LEO Pharma Recent Developments/Updates
        7.10.6 LEO Pharma Competitive Strengths & Weaknesses
    7.11 PROBIOMED
        7.11.1 PROBIOMED Details
        7.11.2 PROBIOMED Major Business
        7.11.3 PROBIOMED Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.11.4 PROBIOMED Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 PROBIOMED Recent Developments/Updates
        7.11.6 PROBIOMED Competitive Strengths & Weaknesses
    7.12 Shanghai Pharmaceuticals Holding Co., Ltd.
        7.12.1 Shanghai Pharmaceuticals Holding Co., Ltd. Details
        7.12.2 Shanghai Pharmaceuticals Holding Co., Ltd. Major Business
        7.12.3 Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Product and Services
        7.12.4 Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Shanghai Pharmaceuticals Holding Co., Ltd. Recent Developments/Updates
        7.12.6 Shanghai Pharmaceuticals Holding Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Tumor Necrosis Factor Inhibitor Drug Industry Chain
    8.2 Tumor Necrosis Factor Inhibitor Drug Upstream Analysis
        8.2.1 Tumor Necrosis Factor Inhibitor Drug Core Raw Materials
        8.2.2 Main Manufacturers of Tumor Necrosis Factor Inhibitor Drug Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Tumor Necrosis Factor Inhibitor Drug Production Mode
    8.6 Tumor Necrosis Factor Inhibitor Drug Procurement Model
    8.7 Tumor Necrosis Factor Inhibitor Drug Industry Sales Model and Sales Channels
        8.7.1 Tumor Necrosis Factor Inhibitor Drug Sales Model
        8.7.2 Tumor Necrosis Factor Inhibitor Drug Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Tumor Necrosis Factor Inhibitor Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Tumor Necrosis Factor Inhibitor Drug Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Tumor Necrosis Factor Inhibitor Drug Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Region (2018-2023)
    Table 5. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Region (2024-2029)
    Table 6. World Tumor Necrosis Factor Inhibitor Drug Production by Region (2018-2023) & (K Units)
    Table 7. World Tumor Necrosis Factor Inhibitor Drug Production by Region (2024-2029) & (K Units)
    Table 8. World Tumor Necrosis Factor Inhibitor Drug Production Market Share by Region (2018-2023)
    Table 9. World Tumor Necrosis Factor Inhibitor Drug Production Market Share by Region (2024-2029)
    Table 10. World Tumor Necrosis Factor Inhibitor Drug Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Tumor Necrosis Factor Inhibitor Drug Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Tumor Necrosis Factor Inhibitor Drug Major Market Trends
    Table 13. World Tumor Necrosis Factor Inhibitor Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Tumor Necrosis Factor Inhibitor Drug Consumption by Region (2018-2023) & (K Units)
    Table 15. World Tumor Necrosis Factor Inhibitor Drug Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Tumor Necrosis Factor Inhibitor Drug Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Tumor Necrosis Factor Inhibitor Drug Producers in 2022
    Table 18. World Tumor Necrosis Factor Inhibitor Drug Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Tumor Necrosis Factor Inhibitor Drug Producers in 2022
    Table 20. World Tumor Necrosis Factor Inhibitor Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Tumor Necrosis Factor Inhibitor Drug Company Evaluation Quadrant
    Table 22. World Tumor Necrosis Factor Inhibitor Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Tumor Necrosis Factor Inhibitor Drug Production Site of Key Manufacturer
    Table 24. Tumor Necrosis Factor Inhibitor Drug Market: Company Product Type Footprint
    Table 25. Tumor Necrosis Factor Inhibitor Drug Market: Company Product Application Footprint
    Table 26. Tumor Necrosis Factor Inhibitor Drug Competitive Factors
    Table 27. Tumor Necrosis Factor Inhibitor Drug New Entrant and Capacity Expansion Plans
    Table 28. Tumor Necrosis Factor Inhibitor Drug Mergers & Acquisitions Activity
    Table 29. United States VS China Tumor Necrosis Factor Inhibitor Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Tumor Necrosis Factor Inhibitor Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Tumor Necrosis Factor Inhibitor Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share (2018-2023)
    Table 37. China Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share (2018-2023)
    Table 42. Rest of World Based Tumor Necrosis Factor Inhibitor Drug Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share (2018-2023)
    Table 47. World Tumor Necrosis Factor Inhibitor Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Tumor Necrosis Factor Inhibitor Drug Production by Type (2018-2023) & (K Units)
    Table 49. World Tumor Necrosis Factor Inhibitor Drug Production by Type (2024-2029) & (K Units)
    Table 50. World Tumor Necrosis Factor Inhibitor Drug Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Tumor Necrosis Factor Inhibitor Drug Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Tumor Necrosis Factor Inhibitor Drug Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Tumor Necrosis Factor Inhibitor Drug Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Tumor Necrosis Factor Inhibitor Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Tumor Necrosis Factor Inhibitor Drug Production by Application (2018-2023) & (K Units)
    Table 56. World Tumor Necrosis Factor Inhibitor Drug Production by Application (2024-2029) & (K Units)
    Table 57. World Tumor Necrosis Factor Inhibitor Drug Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Tumor Necrosis Factor Inhibitor Drug Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Tumor Necrosis Factor Inhibitor Drug Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Tumor Necrosis Factor Inhibitor Drug Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
    Table 62. AbbVie Inc. Major Business
    Table 63. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 64. AbbVie Inc. Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. AbbVie Inc. Recent Developments/Updates
    Table 66. AbbVie Inc. Competitive Strengths & Weaknesses
    Table 67. Amgen Inc. Basic Information, Manufacturing Base and Competitors
    Table 68. Amgen Inc. Major Business
    Table 69. Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 70. Amgen Inc. Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Amgen Inc. Recent Developments/Updates
    Table 72. Amgen Inc. Competitive Strengths & Weaknesses
    Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 74. Johnson & Johnson Major Business
    Table 75. Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 76. Johnson & Johnson Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Johnson & Johnson Recent Developments/Updates
    Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 79. UCB Basic Information, Manufacturing Base and Competitors
    Table 80. UCB Major Business
    Table 81. UCB Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 82. UCB Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. UCB Recent Developments/Updates
    Table 84. UCB Competitive Strengths & Weaknesses
    Table 85. Novartis AG Basic Information, Manufacturing Base and Competitors
    Table 86. Novartis AG Major Business
    Table 87. Novartis AG Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 88. Novartis AG Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Novartis AG Recent Developments/Updates
    Table 90. Novartis AG Competitive Strengths & Weaknesses
    Table 91. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
    Table 92. Pfizer, Inc. Major Business
    Table 93. Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 94. Pfizer, Inc. Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Pfizer, Inc. Recent Developments/Updates
    Table 96. Pfizer, Inc. Competitive Strengths & Weaknesses
    Table 97. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
    Table 98. Merck & Co., Inc. Major Business
    Table 99. Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 100. Merck & Co., Inc. Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Merck & Co., Inc. Recent Developments/Updates
    Table 102. Merck & Co., Inc. Competitive Strengths & Weaknesses
    Table 103. CASI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 104. CASI Pharmaceuticals Major Business
    Table 105. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 106. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CASI Pharmaceuticals Recent Developments/Updates
    Table 108. CASI Pharmaceuticals Competitive Strengths & Weaknesses
    Table 109. EPIRUS Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 110. EPIRUS Biopharmaceuticals Major Business
    Table 111. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 112. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. EPIRUS Biopharmaceuticals Recent Developments/Updates
    Table 114. EPIRUS Biopharmaceuticals Competitive Strengths & Weaknesses
    Table 115. LEO Pharma Basic Information, Manufacturing Base and Competitors
    Table 116. LEO Pharma Major Business
    Table 117. LEO Pharma Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 118. LEO Pharma Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. LEO Pharma Recent Developments/Updates
    Table 120. LEO Pharma Competitive Strengths & Weaknesses
    Table 121. PROBIOMED Basic Information, Manufacturing Base and Competitors
    Table 122. PROBIOMED Major Business
    Table 123. PROBIOMED Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 124. PROBIOMED Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. PROBIOMED Recent Developments/Updates
    Table 126. Shanghai Pharmaceuticals Holding Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 127. Shanghai Pharmaceuticals Holding Co., Ltd. Major Business
    Table 128. Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Product and Services
    Table 129. Shanghai Pharmaceuticals Holding Co., Ltd. Tumor Necrosis Factor Inhibitor Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Tumor Necrosis Factor Inhibitor Drug Upstream (Raw Materials)
    Table 131. Tumor Necrosis Factor Inhibitor Drug Typical Customers
    Table 132. Tumor Necrosis Factor Inhibitor Drug Typical Distributors
List of Figure
    Figure 1. Tumor Necrosis Factor Inhibitor Drug Picture
    Figure 2. World Tumor Necrosis Factor Inhibitor Drug Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Tumor Necrosis Factor Inhibitor Drug Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Tumor Necrosis Factor Inhibitor Drug Production (2018-2029) & (K Units)
    Figure 5. World Tumor Necrosis Factor Inhibitor Drug Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Region (2018-2029)
    Figure 7. World Tumor Necrosis Factor Inhibitor Drug Production Market Share by Region (2018-2029)
    Figure 8. North America Tumor Necrosis Factor Inhibitor Drug Production (2018-2029) & (K Units)
    Figure 9. Europe Tumor Necrosis Factor Inhibitor Drug Production (2018-2029) & (K Units)
    Figure 10. China Tumor Necrosis Factor Inhibitor Drug Production (2018-2029) & (K Units)
    Figure 11. Japan Tumor Necrosis Factor Inhibitor Drug Production (2018-2029) & (K Units)
    Figure 12. Tumor Necrosis Factor Inhibitor Drug Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 15. World Tumor Necrosis Factor Inhibitor Drug Consumption Market Share by Region (2018-2029)
    Figure 16. United States Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 17. China Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 18. Europe Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 19. Japan Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 22. India Tumor Necrosis Factor Inhibitor Drug Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Tumor Necrosis Factor Inhibitor Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Tumor Necrosis Factor Inhibitor Drug Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Tumor Necrosis Factor Inhibitor Drug Markets in 2022
    Figure 26. United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Tumor Necrosis Factor Inhibitor Drug Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Tumor Necrosis Factor Inhibitor Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share 2022
    Figure 30. China Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Tumor Necrosis Factor Inhibitor Drug Production Market Share 2022
    Figure 32. World Tumor Necrosis Factor Inhibitor Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Type in 2022
    Figure 34. Humira
    Figure 35. Enbrel
    Figure 36. Remicade
    Figure 37. Simponi
    Figure 38. Cimzia
    Figure 39. Biosimilars
    Figure 40. World Tumor Necrosis Factor Inhibitor Drug Production Market Share by Type (2018-2029)
    Figure 41. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Type (2018-2029)
    Figure 42. World Tumor Necrosis Factor Inhibitor Drug Average Price by Type (2018-2029) & (US$/Unit)
    Figure 43. World Tumor Necrosis Factor Inhibitor Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 44. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Application in 2022
    Figure 45. Rheumatoid Arthritis
    Figure 46. Psoriatic Arthritis
    Figure 47. Juvenile Idiopathic Arthritis
    Figure 48. Crohn’s Disease
    Figure 49. Ulcerative Colitis
    Figure 50. Others
    Figure 51. World Tumor Necrosis Factor Inhibitor Drug Production Market Share by Application (2018-2029)
    Figure 52. World Tumor Necrosis Factor Inhibitor Drug Production Value Market Share by Application (2018-2029)
    Figure 53. World Tumor Necrosis Factor Inhibitor Drug Average Price by Application (2018-2029) & (US$/Unit)
    Figure 54. Tumor Necrosis Factor Inhibitor Drug Industry Chain
    Figure 55. Tumor Necrosis Factor Inhibitor Drug Procurement Model
    Figure 56. Tumor Necrosis Factor Inhibitor Drug Sales Model
    Figure 57. Tumor Necrosis Factor Inhibitor Drug Sales Channels, Direct Sales, and Distribution
    Figure 58. Methodology
    Figure 59. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

AbbVie Inc.
Amgen Inc.
Johnson & Johnson
UCB
Novartis AG
Pfizer, Inc.
Merck & Co., Inc.
CASI Pharmaceuticals
EPIRUS Biopharmaceuticals
LEO Pharma
PROBIOMED
Shanghai Pharmaceuticals Holding Co., Ltd.

Related Reports

Global Tumor Necrosis Factor Inhibitor Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Tumor Necrosis Factor Inhibitor Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Pharma & Healthcare

Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor.

Global Tumor Necrosis Factor Inhibitor Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Tumor Necrosis Factor Inhibitor Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Tumor Necrosis Factor Inhibitor Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Tumor Necrosis Factor Inhibitor Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>